Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06495892 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PVP-Guided Decongestive Therapy in HF 2

Study acronym: PERIPHERAL-HF2
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Başakşehir Çam & Sakura City Hospital to Başakşehir Çam & Sakura City Hospital Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Jul 1, 2026 to Dec 1, 2026
    • Eligibility criteria expanded, about 13 words
    • Study description expanded, about 11 words
    • Site details revised at 16 of 16 sites
    • Publications: details revised at 2 of 2 entries
  2. Re-verified, no change to tracked fieldsv8
  3. Eligibility criteria expanded, about 21 words
    • Study description expanded, about 19 words
    • Site details revised at 2 of 16 sites
    v7
  4. Collaborators: 15 to 14v6
  5. Study description revised
    • Publications: 1 to 2
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Enrollment target: 600 to 650v4 Show 5 more changesShow less
    • Primary completion date: Jul 15, 2025 to Jul 1, 2025
    • Study completion date: Jul 15, 2026 to Jul 1, 2026
    • Start date: Jul 15, 2024 to Jul 1, 2024
    • Study description expanded, about 6 words
    • Site contacts updated at 2 of 16 sites
  2. Study sites: 18 to 16
    • Collaborators: 17 to 15
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 18
    • Study completion date: Jul 15, 2025 to Jul 15, 2026
    • Collaborators revised (17)
    • Study description expanded, about 3 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.
Trial Details
NCT Number NCT06495892
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Collaborators: Ankara Etlik City Hospital, Akdeniz University, Bağcılar Training and Research Hospital, Bakırçay University, Faculty of Medicine, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Eskişehir City Hospital, İdil State Hospital, Kafkas University Health Research and Application Hospital, Kutahya Health Sciences University, Istanbul Mehmet Akif Ersoy Educational and Training Hospital, Pazarcık State Hospital, Tokat Gaziosmanpasa University, Trakya University, Ataturk University
Conditions
(from sponsor)		 Heart Failure, Congestion, Congestive Heart Failure
Related terms Heart Failure
Enrollment 650 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov